PTGX — Protagonist Therapeutics, Inc. stock price, charts and financials

QT62Protagonist Therapeutics, Inc.

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
135.81
+3.53+2.67%
OverviewShort InterestFilings
PTGXQT62Protagonist Therapeutics, Inc.·NASDAQ
135.81+2.67%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jun 25, 20264Statement of changes in beneficial ownership
Jun 18, 20268-KCurrent report
Jun 11, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
May 14, 20264/AStatement of changes in beneficial ownership (amended)
May 12, 2026SC 13GBeneficial ownership statement (passive)
May 12, 20264Statement of changes in beneficial ownership
May 11, 20264Statement of changes in beneficial ownership
May 05, 20268-KCurrent report
May 05, 202610-QQuarterly report
Apr 30, 2026SC 13GBeneficial ownership statement (passive)
Apr 29, 2026SC 13GBeneficial ownership statement (passive)
Apr 28, 2026DEF 14ADefinitive proxy statement
Apr 28, 2026ARSAnnual report to shareholders
Apr 28, 2026DEFA14AAdditional proxy soliciting materials
Apr 24, 20264Statement of changes in beneficial ownership
Apr 21, 20264Statement of changes in beneficial ownership
Mar 27, 20264Statement of changes in beneficial ownership
Mar 27, 20264Statement of changes in beneficial ownership
Mar 27, 20264Statement of changes in beneficial ownership
Mar 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 25, 20264Statement of changes in beneficial ownership
Feb 25, 20268-KCurrent report
Feb 25, 2026S-8Registration of employee benefit securities
Feb 25, 202610-KAnnual report
#1 / 25 of 289
Page
▼
/ 12